BPC-157 Oral Tablets
Gut healingDescription
Bpc-157 in oral tablet form is specifically studied for gastrointestinal applications. unlike injectable bpc-157 which distributes systemically, oral administration concentrates the peptide in the gi tract — making it the preferred research route for gut lining repair, inflammatory bowel disease models, nsaid-induced gastric injury, and intestinal fistula healing. bpc-157 is notably chemically stable in gastric juice (it was originally isolated from gastric juice), allowing it to retain biological activity through the digestive tract. a 2025 systematic review published in the american journal of gastroenterology synthesized 36 studies (1993–2025) confirming bpc-157's cytoprotective and pro-healing effects across gi ulcer, anastomotic site repair, ibd models, and nsaid-induced injury — with the reviewers noting preclinical safety with no adverse organ system effects. oral bpc-157 is frequently studied for gastroprotection and leaky gut conditions. works synergistically with injectable tb-500 for systemic healing goals. for research and educational purposes only.
Specifications
| Amount in Vial | 15mg (30 tablets) |
|---|---|
| BAC Water | n/a |
| Amount per Unit | 500mcg per tablet |
| Recommended Dose | 500mcg to 1000mcg (1 to 2 tablets) |
| Frequency | Daily |
| Injection Type | Oral tablets |
| Timing | As Needed Take with Meals |
Dose Calculator
Based on 500mcg per tablet (100-unit insulin syringe)
Quick Reference
Reconstitution
Vial size: 15mg (30 tablets)
Add BAC water: n/a
Concentration: 500mcg per tablet
For research and educational use only.
This page provides research dosing information only. Not intended as medical advice. Consult a qualified professional before any use.